Literature DB >> 24900300

Synthesis and antibacterial activity of a novel class of 15-membered macrolide antibiotics, "11a-azalides".

Tomohiro Sugimoto1, Tetsuya Tanikawa1.   

Abstract

An efficient method for the reconstruction of the 9-dihydroerythromycin A macrolactone skeleton has been established. The key steps are oxidative cleavage at the 11,12-position and reconstruction after insertion of an appropriate functionalized amino alcohol. Novel 15-membered macrolides, we named as "11a-azalides", were synthesized based on the above methodology and evaluated for their antibacterial activity. Among them, (13R)-benzyloxymethyl-11a-azalide showed the most potent Streptococcus pneumoniae activity, with improved activity against a representative erythromycin-resistant strain compared to clarithromycin (CAM).

Entities:  

Keywords:  11a-azalide; Antibiotic; macrolide; novel scaffold; resistant-pathogen

Year:  2010        PMID: 24900300      PMCID: PMC4018107          DOI: 10.1021/ml100252s

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  14 in total

1.  Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Authors:  G V Doern; K P Heilmann; H K Huynh; P R Rhomberg; S L Coffman; A B Brueggemann
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Clinical implications of macrolide resistance in community-acquired respiratory tract infections.

Authors:  Daryl J Hoban; George G Zhanel
Journal:  Expert Rev Anti Infect Ther       Date:  2006-12       Impact factor: 5.091

3.  Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1).

Authors:  Ahmed F. Abdel-Magid; Kenneth G. Carson; Bruce D. Harris; Cynthia A. Maryanoff; Rekha D. Shah
Journal:  J Org Chem       Date:  1996-05-31       Impact factor: 4.354

Review 4.  Pharmacokinetics of Erythromycin in man.

Authors:  J T Wilson; C J van Boxtel
Journal:  Antibiot Chemother (1971)       Date:  1978

Review 5.  Recent developments in macrolide antimicrobial research.

Authors:  Toshifumi Asaka; Akira Manaka; Hiroyuki Sugiyama
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

6.  Acid degradation of erythromycin A and erythromycin B.

Authors:  P Kurath; P H Jones; R S Egan; T J Perun
Journal:  Experientia       Date:  1971-04-15

7.  15-amido erythromycins: synthesis and in vitro activity of a new class of macrolide antibiotics.

Authors:  Simon J Shaw; Darren Abbanat; Gary W Ashley; Karen Bush; Barbara Foleno; Mark Macielag; Dan Zhang; David C Myles
Journal:  J Antibiot (Tokyo)       Date:  2005-03       Impact factor: 2.649

8.  Novel azalides derived from 16-membered macrolides. Part II: Isolation of the linear 9-formylcarboxylic acid and its sequential macrocyclization with an amino alcohol or an azidoamine.

Authors:  Tomoaki Miura; Kenichi Kanemoto; Satomi Natsume; Kunio Atsumi; Hideki Fushimi; Takuji Yoshida; Keiichi Ajito
Journal:  Bioorg Med Chem       Date:  2008-09-25       Impact factor: 3.641

Review 9.  Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004.

Authors:  David Felmingham; Rafael Cantón; Stephen G Jenkins
Journal:  J Infect       Date:  2007-06-12       Impact factor: 6.072

Review 10.  The evolution and role of macrolides in infectious diseases.

Authors:  Joseph M Blondeau
Journal:  Expert Opin Pharmacother       Date:  2002-08       Impact factor: 3.889

View more
  1 in total

Review 1.  The macrolide antibiotic renaissance.

Authors:  George P Dinos
Journal:  Br J Pharmacol       Date:  2017-08-10       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.